Search results for "diagnostic"

showing 10 items of 8913 documents

Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing th…

2015

Enhancing delivery of antigens to dendritic cells (DCs) is essential for the induction of vigorous antigen-specific cellular immune responses. Aim of the present study was to evaluate the properties of hydroxyethyl starch nanocapsules (HES-NCs) functionalized with anti-CD40, anti-DEC205, interferon-γ (IFNγ) and/or monophosphoryl lipid A (MPLA) with respect to the overall uptake, the released cytokine profile, and the influence on phenotypic maturation of human monocyte-derived DCs using flow cytometry, confocal microscopy and enzyme-linked immunosorbent assays. NC uptake by DCs was significantly enhanced by functionalizing NCs with anti-CD40 or MPLA. With respect to the cytokine profile and…

medicine.medical_treatmentMonophosphoryl Lipid ANanocapsulesFlow cytometryHydroxyethyl Starch DerivativesImmune systemAntigenAdjuvants ImmunologicNanocapsulesInterferonmedicineHumansCells CulturedMicroscopy ConfocalGeneral VeterinaryGeneral Immunology and Microbiologymedicine.diagnostic_testChemistryPublic Health Environmental and Occupational HealthDendritic CellsTh1 CellsInterleukin-12Cell biologyToll-Like Receptor 4Infectious DiseasesLipid ANanomedicineBiochemistryMolecular MedicineAdjuvantCD80medicine.drugVaccine
researchProduct

Evaluation of orthognathic surgery on articular disc position and temporomandibular joint symptoms in skeletal class II patients: A Magnetic Resonanc…

2017

BACKGROUND The purpose of orthognathic surgery is to correct facial deformity and dental malocclusion and to obtain normal orofacial function. However, there are controversies of whether orthognathic surgery might have any negative influence on temporomandibular (TM) joint. The purpose of this study was to evaluate the influence of orthognathic surgery on articular disc position and temporomandibular joint symptoms of skeletal CI II patients by means of magnetic resonance imaging. MATERIAL AND METHODS For this purpose, fifteen patients with skeletal CI II malocclusion, aged 19-32 years (mean 23 years), 10 women and 5 men, from the Isfahan Department of Oral and Maxillofacial Surgery were st…

medicine.medical_treatmentOrthognathic surgeryDentistryCondyle03 medical and health sciences0302 clinical medicine0502 economics and businessMedicineGeneral DentistryDental malocclusionOrthodonticsmedicine.diagnostic_testbusiness.industryResearch05 social sciencesMagnetic resonance imaging030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Temporomandibular jointPosition (obstetrics)medicine.anatomical_structureUNESCO::CIENCIAS MÉDICASOral and maxillofacial surgery050211 marketingMalocclusionOral SurgerybusinessJournal of Clinical and Experimental Dentistry
researchProduct

Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres

2015

Abstract Although cancer stem-like cells (CSCs) are rare, they can enter a non-proliferative or dormant state and resist therapy. Furthermore, quiescent CSCs are responsible for metastases that can appear after curative surgical treatment of a primary tumor. Because of drug resistance of CSCs, the development of novel therapies is urgently required that specifically target CSCs. Purpose The aim of the present study was to investigate the potential of a panel of natural products and derivatives to inhibit CSC-enriched mammospheres of MCF-7 breast cancer cells. Methods CD44high/CD24low cells were identified by flow cytometry and maintained as mammospheres. As a control, we used two clinically…

medicine.medical_treatmentPhytochemicalsCellArtesunatePharmaceutical ScienceAntineoplastic AgentsBiologyPharmacologyFlow cytometrySpheroids CellularStilbenesDrug DiscoverymedicineHumansCytotoxicityPharmacologyChemotherapymedicine.diagnostic_testCancermedicine.diseasePrimary tumorArtemisininsSalicylatesmedicine.anatomical_structureComplementary and alternative medicineDocetaxelMCF-7MCF-7 CellsNeoplastic Stem CellsMolecular MedicineNaphthoquinonesmedicine.drugPhytomedicine
researchProduct

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics

2021

Over the last two decades, pharmacogenetics and pharmacokinetics have been increasingly used in clinical practice in Psychiatry due to the high variability regarding response and side effects of antipsychotic drugs. Specifically, long-acting injectable (LAI) antipsychotics have different pharmacokinetic profile than oral formulations due to their sustained release characteristics. In addition, most of these drugs are metabolized by CYP2D6, whose interindividual genetic variability results in different metabolizer status and, consequently, into different plasma concentrations of the drugs. In this context, there is consistent evidence which supports the use of therapeutic drug monitoring (TD…

medicine.medical_treatmentPopulationAripiprazolePharmaceutical ScienceContext (language use)ReviewPharmacology030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicinearipiprazolePharmacy and materia medicamedicineAntipsychoticsPaliperidoneeducationAntipsychoticPopulation pharmacokinetic modelspharmacogeneticseducation.field_of_studyRisperidonerisperidonemedicine.diagnostic_testbusiness.industryCYP2D6PaliperidoneRisperidoneLAIRS1-441antipsychoticsTherapeutic drug monitoringpopulation pharmacokinetic modelsPharmacogeneticsAripiprazolebusinesspaliperidone030217 neurology & neurosurgeryPharmacogeneticsmedicine.drug
researchProduct

68 ga-dotatoc pet/ct follow up after single or hypofractionated gamma knife icon radiosurgery for meningioma patients

2021

68Ga-DOTATOC represents a useful tool in tumor contouring for radiosurgery planning. We present a case series of patients affected by meningiomas on who we performed 68Ga-DOTATOC positron emission tomography (PET)/CT pre-operatively, a subgroup of which also underwent a post-operative 68Ga-DOTATOC PET/CT to evaluate the standardized uptake value (SUV) modification after Gamma Knife ICON treatment in single or hypofractionated fractions. Twenty patients were enrolled/included in this study: ten females and ten males. The median age was 52 years (range 33–80). The median tumor diameter was 3.68 cm (range 0.12–22.26 cm), and the median pre-radiotherapy maximum SUV value was 11 (range 2.3–92). …

medicine.medical_treatmentStandardized uptake valueGalliumGamma knifeRadiosurgeryRadiosurgeryArticlelcsh:RC321-57168ga dotatocMeningioma03 medical and health sciences<sup>68</sup>Ga-DOTATOC PET/CT0302 clinical medicinemedicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryPET-CTContouringmedicine.diagnostic_testbusiness.industryGamma KnifeGeneral NeuroscienceFollow upmedicine.diseasePositron emission tomography030220 oncology & carcinogenesisNuclear medicinebusiness68Ga-DOTATOC PET/CTMeningiomaHypofractionated030217 neurology & neurosurgery
researchProduct

Descriptive study on subjective experience of genetic testing with respect to relationship, family planning and psychosocial wellbeing among women wi…

2021

AbstractBackgroundDue to increased risk of endometrial and ovarian cancer, women belonging to known Lynch Syndrome (LS) families are recommended to undergo germline testing. Current practice in Finland is to offer counselling to women with pathogenic variant and advocate risk-reducing surgery (RRS) after completion of childbirth. The present study aimed to clarify the impacts of positive germline testing on family planning and reproductive decisions of these women, which are relatively unknown.MethodsSeventy-nine carriers of germline MMR gene pathogenic variant (path_MMR)were identified from the Finnish LS Registry as having genetic testing performed before the age of 45 years and not havin…

medicine.medical_treatmentTestingQH426-470ihmissuhteetCOLORECTAL-CANCER0302 clinical medicinehenkinen hyvinvointi5. Gender equality3123 Gynaecology and paediatricsChildbirthGenetics (clinical)RC254-282media_common0303 health sciencesmedicine.diagnostic_test030305 genetics & heredityNeoplasms. Tumors. Oncology. Including cancer and carcinogensLynch syndrometesting3. Good healthOncologyhereditary cancerFamily planning030220 oncology & carcinogenesissyöpätauditPsychosocialClinical psychologymedia_common.quotation_subject3122 CancersFertilityMUTATION CARRIERSPsychosocial wellbeingtestaus03 medical and health sciencesCHILDBEARINGmedicineGeneticsFERTILITYLynchin oireyhtymäGenetic testingperinnölliset tauditbusiness.industryEndometrial cancerResearchOophorectomyENDOMETRIAL CANCERmedicine.diseaseHereditary cancerperhesuunnitteluLynch syndromerelationshipsRelationshipsbusinesspsychosocial wellbeing
researchProduct

Neural Mechanisms of Acceptance and Commitment Therapy for Chronic Pain: A Network-Based fMRI Approach

2021

AbstractOver 100 million Americans suffer from chronic pain (CP), which causes more disability than any other medical condition in the U.S. at a cost of $560-$635 billion per year (IOM, 2011). Opioid analgesics are frequently used to treat CP. However, long term use of opioids can cause brain changes such as opioid-induced hyperalgesia that, over time, increase pain sensation. Also, opioids fail to treat complex psychological factors that worsen pain-related disability, including beliefs about and emotional responses to pain. Cognitive behavioral therapy (CBT) can be efficacious for CP. However, CBT generally does not focus on important factors needed for long-term functional improvement, i…

medicine.medical_treatmentgraph theoryneural mechanismNIH ToolboxAcceptance and commitment therapylcsh:RC321-57103 medical and health sciencesBehavioral Neuroscience0302 clinical medicineQuality of life (healthcare)030202 anesthesiologymedicineAcceptance and Commitment Therapylcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryDefault mode networkOriginal Researchmedicine.diagnostic_testbusiness.industryfunctional connectivityfMRIChronic painCognitionCenter for Epidemiologic Studies Depression Scalemedicine.diseasebrain networksCognitive behavioral therapyPsychiatry and Mental healthNeuropsychology and Physiological PsychologyNeurologyFunctional magnetic resonance imagingbusinesschronic pain030217 neurology & neurosurgeryClinical psychologyNeuroscienceFrontiers in Human Neuroscience
researchProduct

PRESENTAZIONE DI UN CASO DI MENINGOCELE SACRALE ANTERIORE: CARATTERISTICHE NEURORADIOLOGICHE E DIAGNOSI DIFFERENZIALE

2013

SCOPO DEL LAVORO: Lo scopo di questo lavoro è documentare un caso di meningocele sacrale anteriore (Anterior Sacral Meningocele, ASM) rara forma di disrafismo spinale, diagnosticato in una giovane di 13 anni con riscontro ecografico di formazione cistica di verosimile pertinenza annessiale dopo visita Specialistica Ginecologica. La paziente si presenta con una clinica caratterizzata da: dolore pelvico, costipazione e cistiti ricorrenti. Sarà inoltre fatto un breve excursus sulle possibili diagnosi differenziali con altre masse pelviche a sviluppo presacrale. MATERIALI E METODI: A seguito di consulenza ginecologica, la paziente è stata sottoposta ad una ecografia transaddominale, che ha e…

meningocele sacrale anteriore semeiotica neuroradiologica diagnosi differenzialeSettore MED/50 - Scienze Tecniche Mediche ApplicateSettore MED/37 - NeuroradiologiaSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

European guidelines on chronic mesenteric ischaemia - joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy an…

2020

Chronic mesenteric ischaemia is a severe and incapacitating disease, causing complaints of post-prandial pain, fear of eating and weight loss. Even though chronic mesenteric ischaemia may progress to acute mesenteric ischaemia, chronic mesenteric ischaemia remains an underappreciated and undertreated disease entity. Probable explanations are the lack of knowledge and awareness among physicians and the lack of a gold standard diagnostic test. The underappreciation of this disease results in diagnostic delays, underdiagnosis and undertreating of patients with chronic mesenteric ischaemia, potentially resulting in fatal acute mesenteric ischaemia. This guideline provides a comprehensive overvi…

mesenteric artery stentingComputed Tomography AngiographyFOCUSED UPDATEContrast MediaARTERY COMPRESSION SYNDROMEDiseaseGuidelineSettore MED/22 - Chirurgia VascolareSeverity of Illness Indexatherosclerosi0302 clinical medicineIschemiaMesenteric Vascular Occlusionatherosclerosis; coeliac artery release; Median arcuate ligament syndrome; mesenteric arteries; mesenteric artery stenting610 Medicine &amp; healthMesenteric arteriesmesenteric arteriesSocieties MedicalNetherlandsSUPERIOREvidence-Based MedicineGASTRIC EXERCISE TONOMETRYmedicine.diagnostic_testGastroenterologyDUAL ANTIPLATELET THERAPYENHANCED MR-ANGIOGRAPHYEuropeTreatment Outcomemedicine.anatomical_structureOncology030220 oncology & carcinogenesisRadiological weaponSURGICAL-TREATMENT030211 gastroenterology & hepatologyRadiologyMedian arcuate ligament syndromeSTENT PLACEMENTmedicine.medical_specialtyANTITHROMBOTIC THERAPYMedian arcuate ligament syndromeRisk Assessment03 medical and health sciencescoeliac artery releasemedicineHumanscardiovascular diseasesIntensive care medicinePatient Care TeamMEDIAN ARCUATE LIGAMENTbusiness.industryGold standardEndoscopyGuidelinemesenteric arteriemedicine.diseaseEndoscopyMesenteric ischemiaMesenteric IschemiaChronic DiseaseInterdisciplinary CommunicationatherosclerosisbusinessMagnetic Resonance Angiography
researchProduct

Chronic Mesenteric Ischemia: Critical review and guidelines for management

2011

Background CMI is caused by chronic occlusive disease of mesenteric arteries. In such an uncommon disease, clear recommendations are strongly needed. Unfortunately, treatment options for symptomatic CMI are still controversial and no guidelines exist. Methods A systematic literature review of the last 25-years was conducted through MEDLINE, Embase, and Cochrane Review/Trials register to identify studies reporting on CMI treatment with more than 10 patients. Primary outcomes were perioperative mortality and morbidity rates. Secondary outcomes were survival rates, primary and secondary patency rates, vessels treated, CMI recurrence, follow-up (FU), technical success (TS), and in-hospital leng…

mesenteric chronic ischemia vascular surgeryPediatricsmedicine.medical_specialtyTime FactorsMEDLINE610 Medicine & healthDiseaseSettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineIschemiaRecurrenceRisk FactorsMesenteric Vascular OcclusionmedicineHumansVascular PatencyVascular DiseasesSurvival rateVascular PatencyChi-Square Distributionbusiness.industry10042 Clinic for Diagnostic and Interventional RadiologyPatient Selection10031 Clinic for AngiologyEndovascular ProceduresGeneral MedicinePerioperativeLength of Staymedicine.disease10020 Clinic for Cardiac Surgery2746 SurgeryTreatment OutcomeSystematic reviewMesenteric ischemiaMesenteric IschemiaPractice Guidelines as TopicSurgeryCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresChi-squared distributionAlgorithms
researchProduct